---
title: Clinical Trial Data Management - TD2 Precision Oncology
description: Discover safe & effective pharmaceutical agents with TD2's in vivo PK services. Tailored DMPK platform for precise drug development strategies
image: https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# Clinical Trial Data Management

![Clinical Trial Data Management](https://td2inc.com/hs-fs/hubfs/Assets/Icon/data-analysis.png?width=150&name=data-analysis.png)

At TD2, our experienced data management team includes data managers, data coordinators, clinical database programmers, and clinical data reviewers. Our data management services encompass a wide range of capabilities, ensuring your oncology trials are executed with precision and efficiency. With TD2’s comprehensive data management capabilities and expertise, we are your trusted partner, enabling you to focus on advancing your innovative therapeutics.

**CRF Design Expertise:** We design case report forms (CRFs) in accordance with the Clinical Data Acquisition Standards Harmonization (CDASH) standard, streamlining data collection and ensuring data consistency.

**Real-Time Metrics:** TD2 provides real-time clinical trial metrics, enabling proactive decision-making and trial management.

**Data Quality Assurance:** Our team conducts double-data entry for paper CRFs to minimize errors and maintain data accuracy.

**Data Review and Query Generation:** We review clinical data for errors and trends, promptly generating electronic queries for resolution.

**System Validation:** We meticulously validate all project-specific components of the data management system to ensure it meets your trial’s unique requirements.

**Data Integration:** We seamlessly integrate data from external sources, ensuring alignment and consistency with CRF data.

**CDISC Compliance:** We deliver a clean, analyzable database adhering to the Clinical Data Interchange Standards Consortium (CDISC) standards, promoting regulatory compliance and data consistency.

**Adverse Event Reconciliation:** We meticulously reconcile serious adverse events, ensuring accurate reporting and patient safety.

**Platform Flexibility:** Our team seamlessly operates within multiple Electronic Data Capture (EDC) platforms, accommodating your preferred tools and workflows.

“There are countless opportunities to learn and grow at TD2. From designing the eCRFs, creating therapeutic area standards, hands-on programming, exploring existing platforms and adapting new ones, to managing data throughout trials, and ensuring patient safety to produce clean data for analysis and submissions. At TD2 you explore, innovate, discover, implement, and achieve!”

**– Current Sr. Data Manager**

### Request more information about our Clinical Trial Services

Contact our experts to help advance your drug development with TD2's Comprehensive Oncology Ecosystem.

## Additional Resources

[![Climbing the Mountain: Current Challenges in Early Phase Oncology Clinical Trials](https://td2inc.com/hubfs/mountain.jpg)](https://blog.td2inc.com/climbing-the-mountain-current-challenges-in-early-phase-oncology-clinical-trials?hsLang=en)

Blog

## [Climbing the Mountain: Current Challenges in Early Phase Oncology Clinical Trials](https://blog.td2inc.com/climbing-the-mountain-current-challenges-in-early-phase-oncology-clinical-trials?hsLang=en)

[![Leading the way in defining a new Immunotherapy Response Score (IRS) to predict checkpoint inhibitor benefit](https://td2inc.com/hubfs/pd-l1-graphic.png)](https://td2inc.com/lp-publication-development-and-validation-of-an-integrative-pan-solid-tumor-predictor-of-pd-1-pd-l1-blockade-benefit/?hsLang=en)

Clinical, Preclinical, Posters and Publications

## [Leading the way in defining a new Immunotherapy Response Score (IRS) to predict checkpoint inhibitor benefit](https://td2inc.com/lp-publication-development-and-validation-of-an-integrative-pan-solid-tumor-predictor-of-pd-1-pd-l1-blockade-benefit/?hsLang=en)

[![Early Phase Oncology Trial Designs Phase I Strategies Tailored for Success](https://td2inc.com/hubfs/wp-thumb-early-phase.png)](https://td2inc.com/wp-early-phase-oncology-trial-designs/?hsLang=en)

Clinical, White Papers

## [Early Phase Oncology Trial Designs Phase I Strategies Tailored for Success](https://td2inc.com/wp-early-phase-oncology-trial-designs/?hsLang=en)

[![TD2 Clinical Capabilities](https://td2inc.com/hubfs/thumb-td2-clinical-capabilities.jpeg)](https://td2inc.com/hubfs/Assets/Videos/TD2-Clinical-Capabilities.mp4?hsLang=en)

Videos

## [TD2 Clinical Capabilities](https://td2inc.com/hubfs/Assets/Videos/TD2-Clinical-Capabilities.mp4?hsLang=en)

Load More

![Preclinical Models and Services](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-clinical-study-management.png?width=101&height=85&name=icon-clinical-study-management.png)

### Comprehensive

## Clinical Trial Services Include:

- [Study design & protocol development](https://td2inc.com/protocol-design/?hsLang=en)
- [Patient identification and site engagement](https://td2inc.com/lp-patient-identification-and-site-engagement/?hsLang=en)
- [Site management and monitoring](https://td2inc.com/comprehensive-site-management-and-monitoring?hsLang=en)
- [Third-party vendor management](https://td2inc.com/strategic-third-party-vendor-management?hsLang=en)
- [Biostatistics](https://td2inc.com/biostatistics?hsLang=en)

**Therapeutic Areas:**

- [Radiopharmaceuticals](https://td2inc.com/clinical-trial-services-for-radiopharmaceuticals?hsLang=en)
- [Hematologic Malignancies](https://td2inc.com/comprehensive-clinical-trial-services-for-hematologic-malignancies?hsLang=en)
- [Antibody-Drug Conjugates](https://td2inc.com/clinical-trial-services-for-antibody-drug-conjugates?hsLang=en)
- [Small Molecules](https://td2inc.com/clinical-trial-services-for-small-molecules?hsLang=en)
- [Cancer Vaccine Development](https://td2inc.com/cancer-vaccine-development?hsLang=en)

- [Data management](https://td2inc.com/lp-data-management/?hsLang=en)
- [Pharmacovigilance](https://td2inc.com/pharmacovigilance?hsLang=en)
- [Medical monitoring](https://td2inc.com/medical-monitoring-services?hsLang=en)
- [eTMF management](https://td2inc.com/etmf-management-services?hsLang=en)
- [Quality Assurance](https://td2inc.com/quality-assurance-services?hsLang=en)

## GET STARTED

## Work with a team who believes in your research as much as you do.

Are you ready to accelerate your drug development? Partner with a collaborative oncology CRO that believes in your treatment as much as you do. Take the first step today and contact our experts.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)